Objective To identify genetic variants associated with sepsis (early-onset and late-onset) using a genome-wide association (GWA) analysis in a cohort of extremely premature infants. Study design Previously generated GWA data from the Neonatal Research Network's anonymised genomic database biorepository of extremely premature infants were used for this study. Sepsis was defined as culturepositive early-onset or late-onset sepsis or culture-proven meningitis. Genomic and whole-genome-amplified DNA was genotyped for 1.2 million single-nucleotide polymorphisms (SNPs); 91% of SNPs were successfully genotyped. We imputed 7.2 million additional SNPs. p Values and false discovery rates (FDRs) were calculated from multivariate logistic regression analysis adjusting for gender, gestational age and ancestry. Target statistical value was p<10 −5
ABSTRACT
Objective To identify genetic variants associated with sepsis (early-onset and late-onset) using a genome-wide association (GWA) analysis in a cohort of extremely premature infants. Study design Previously generated GWA data from the Neonatal Research Network's anonymised genomic database biorepository of extremely premature infants were used for this study. Sepsis was defined as culturepositive early-onset or late-onset sepsis or culture-proven meningitis. Genomic and whole-genome-amplified DNA was genotyped for 1.2 million single-nucleotide polymorphisms (SNPs); 91% of SNPs were successfully genotyped. We imputed 7.2 million additional SNPs. p Values and false discovery rates (FDRs) were calculated from multivariate logistic regression analysis adjusting for gender, gestational age and ancestry. Target statistical value was p<10 −5 . Secondary analyses assessed associations of SNPs with pathogen type. Pathway analyses were also run on primary and secondary end points. Results Data from 757 extremely premature infants were included: 351 infants with sepsis and 406 infants without sepsis. No SNPs reached genome-wide significance levels (5×10 −8 ); two SNPs in proximity to FOXC2 and FOXL1 genes achieved target levels of significance. In secondary analyses, SNPs for ELMO1, IRAK2 (Gram-positive sepsis), RALA, IMMP2L (Gramnegative sepsis) and PIEZO2 (fungal sepsis) met target significance levels. Pathways associated with sepsis and Gram-negative sepsis included gap junctions, fibroblast growth factor receptors, regulators of cell division and interleukin-1-associated receptor kinase 2 ( p values<0.001 and FDR<20%).
Conclusions No SNPs met genome-wide significance in this cohort of extremely low birthweight infants; however, areas of potential association and pathways meriting further study were identified.
BACKGROUND
Sepsis is a potentially life-threatening illness, affecting 10-20% of neonates worldwide, with a higher incidence in preterm and very low birthweight infants. 1 2 Up to one-third of extremely premature infants develop sepsis, which carries a high mortality and morbidity. [1] [2] [3] Susceptibility to neonatal sepsis is mediated by complex interactions between environmental and maternal factors and the neonatal immune response, which may be modified by differences in genetic composition or function. [3] [4] [5] Twin studies and ethnic variations suggest that host genetic factors may contribute to susceptibility to sepsis. [4] [5] [6] [7] [8] Genetic studies of sepsis in newborns have previously used candidate gene approaches, with varied findings.
9-14
While genome-wide association studies (GWAS) have been performed in adult sepsis, no GWAS has reported genetic variation in risk of sepsis in extremely preterm infants. [15] [16] [17] An agnostic GWAS approach rather than a study on known variant candidate genes has potential to identify gene variants across many genes (≥1 million variants), including disease associations with previously unknown genes. In addition, investigators do not What is already known on this topic? ▸ Sepsis is a major comorbidity in extremely low birthweight infants. ▸ Preterm infants may have genetic susceptibility to infection.
What this study adds?
▸ In a genome-wide association study in extremely low birthweight infants with sepsis, we identified several over-represented single-nucleotide polymorphisms (SNPs) related to innate immunity, although none met genome-wide significance. ▸ Alteration of gut and respiratory epithelial integrity mediated by these SNPs and related pathways may be an important mechanism of increased sepsis risk.
possess sufficient knowledge of the function of all genes to predict candidate genes well. The high rate of sepsis in extremely low birthweight (ELBW) neonates establishes them as a unique population for unbiased study of genetic associations with sepsis. 4 
METHODS

Study population and data source
We performed a secondary analysis using an anonymised DNA biorepository from a prior study of cytokines and neurodevelopmental outcomes in ELBW infants conducted by the Eunice Kennedy Shriver NICHD Neonatal Research Network (NRN). 18 19 Enrolled infants were <1000 g birth weight and <72 hours old at enrolment; infants with major congenital anomalies were excluded. The NRN's anonymised DNA database and biorepository was previously approved by all site institutional review boards (IRBs) for candidate gene analyses and genome-wide analyses of diseases associated with extreme prematurity, including sepsis. 20 We received a waiver of IRB authorisation for use of this anonymised data set. In this multiracial and multiethnic study, blood spot samples were collected on >800 ELBW infants and analysed using the Illumina Omni-1 Quad array. 20 
Primary outcome
Our primary outcome was the identification of single-nucleotide polymorphisms (SNPs) significantly associated with the occurrence of all sepsis in extremely preterm infants.
Secondary outcomes
Given that early-onset sepsis (EOS) and late-onset sepsis (LOS) have distinct aetiologies and likely differences in mechanisms underpinning their pathogenesis, we planned a priori to identify SNPs significantly associated with LOS alone. 3 21 Due to the relatively low incidence of EOS, it was not feasible to examine SNPs associated with EOS alone. We also identified SNPs associated with Gram-positive, Gram-negative and fungal pathogens. While infants who experienced multiple episodes of sepsis with different bacterial pathogens were included only once in the primary analysis, they were included in each pathogen category that they fit in secondary analyses. Finally, we also reviewed SNPs tested in previous candidate gene association studies in neonatal sepsis.
Study definitions
Cases consisted of infants with one or more episodes of cultureproven sepsis (EOS or LOS) or meningitis, treated with antibiotics for ≥5 days, or who died before treatment was completed. 1 2 Controls were infants not classified as cases. Infants with positive blood or cerebrospinal fluid cultures were defined as having culture proven sepsis. EOS comprised infants with cultureproven sepsis in the first 72 hours of life, while LOS comprised cases beyond that timeframe. All subjects included in the study were followed through the duration of their hospital course for occurrence of sepsis.
Sample source and storage
Our study used DNA data obtained from samples originally collected as part of a prospective multicentre cohort study of cytokines in premature infants (the Cytokine Study, performed in 17 centres of the National Institute of Child Health and Human Development Neonatal Research Network). 18 In the parent study, whole-blood spots were obtained on filter paper within 4 hours after birth and at serial timepoints (days 3, 7, 14 and 21). These filter paper blood spots were frozen as soon as possible. For our study and other secondary genomic analyses performed using this data set, DNA was extracted from filter paper blood spots for the earliest age available for each subject, amplified and analysed using the Illumina Omni-1 Quad array, as described below. Additional details regarding sample methods are available in prior studies using this sample set. 18 20 
Genomic analysis
Genomic and whole-genome-amplified DNA were genotyped on the Human-OMNI1-Quad_v1-0_B BeadChip platform (Illumina, San Diego, California). Initially, 1.2 million SNPs were tested, of which >900 000 (91%) were successfully genotyped. We employed standard quality control thresholds and included samples and SNPs with >97% call rate, while excluding minor allele frequencies <1%. Additionally, 7.2 million SNPs were imputed against the HapMap 3 cosmopolitan reference panel with Impute2. 20 All SNP-gene assignments were made based on the University of California, Santa Cruz gene tracks within the GRCh37/hg19 genome build. 22 23 Genotypes and a subset of subject information inclusive of key characteristic and outcome phenotype data have been stored, with no identifying links, in the National Human Genome Research Institute Database of Genotypes and Phenotypes (dbGaP Study Accession: phs000353.v1.p1). 19 20 
Data analysis
Following standard quality checks, single and multiple logistic regression models were developed for the primary and secondary analyses. Covariates included in the multiple regression model included gestational age, small for gestational age (SGA) status, ancestry, surgery, caesarean section and the first four eigenvalues for ancestry (described below). In previous analyses of this data set, these covariates were determined to be the most important predictors of sepsis. 8 To minimise false discoveries, we established a conservative significance level of 10 −5 as the 'target' for reporting, while a p value of 5×10 −8 is regarded as a 'genome-wide' association. The latter value is widely accepted to be the threshold in GWAS that would adequately adjust for the multiple comparisons involved and is estimated to correspond to a p value of 0.05 in a classical epidemiological study testing a single hypothesis. [22] [23] [24] [25] We used this two-tiered approach in order to screen for genes of interest, which may be missed if only the more stringent threshold were applied. When SNPs met threshold significance, we did not limit reporting based on FDR thresholds in order to better identify any genes of putative biological importance that should be examined closely in future validation studies. 25 p Values were calculated per SNP for a one degree of freedom additive model. For the secondary analysis of previously identified candidate SNPs, we reported p values <0.05 as trends of interest.
Correction for population stratification
Spurious associations may be obtained, or true associations overlooked, if allele frequencies differ between subpopulations and are represented unequally between cases and controls due to systematic ancestry differences. [26] [27] [28] The first four eigenvalues derived from linkage disequilibrium pruned for genotyped SNPs were included as covariables in primary and secondary analyses to adjust for individual ancestry (eigenvalues generated using GWAS-Tools). 20 
Exploratory pathway analysis
We assigned genes to biological pathways using the Reactome database (http://www.reactome.org) using the adaptive rank truncated product (ARTP) method ( pathway tools package ARTP). [29] [30] [31] SNPs were notated to genes based on their location within 50 kb of the gene models defined in Refseq, and p values assigned based on the results of the GWA analysis. A summary of the association between each gene and sepsis was generated based on the multiple-testing-adjusted p value associated with the most significant SNP within that gene. The ARTP method was used to combine gene-level p values into a test statistic for the pathway association with sepsis. 31 Given the exploratory nature of this analysis, we designated pathways with p values <0.005 as the cut-off for reporting and reported false discovery rates (FDRs) of <20% to facilitate assessment of the strength of the evidence. 25 
RESULTS
Data from 751 ELBW infants passed quality control checks and were included in the analysis. This cohort included 345 infants with sepsis (see online supplementary table S1). Most infants with sepsis had experienced LOS (320 infants, 393 episodes). Ninety-nine infants experienced more than one episode of sepsis. Gram-positive pathogens were present in more than three quarters of the LOS events (252 episodes), while Gram-negative and fungal sepsis occurred with lower frequency (72 and 69 episodes, respectively; see online supplementary table S1). Infants could be positive for more than one organism per sepsis event. Of the infants with sepsis, 42 were diagnosed with culture-proven meningitis. Eighty-one infants in the overall cohort developed necrotising enterocolitis (NEC), including 40 cases of surgical NEC. NEC events occurred more frequently in infants with sepsis compared with uninfected infants (14.1% vs 8.7%, p=0.02, χ 2 test); however, the data set lacked information on timing of NEC in relation to sepsis event.
Primary outcome
In the primary analysis of overall sepsis, no SNPs reached a priori genome-wide significance levels (5×10 −8 ); however, several achieved p values of 10 −5 (table 1) . While these SNPs were generally noted to be in intergenic regions, several were located on chromosome 16, in proximity to genes for FOXC2 (forkhead box protein C2) and FOXL1 (forkhead box protein
Secondary outcomes
Examining Gram-positive LOS only, SNPs that achieved target level of associations (<10 −5 ) included introns for ELMO1 (engulfment and cell motility 1) on chromosome 7 and introns for VIL1 (villin 1, chromosome 2) (see table 2 and online supplementary figure S2A,B) . For Gram-negative LOS, SNPs in introns for RALA (Ras-like protein A) and IMMP2L (inner mitochondrial membrane peptidase-2 like), located on chromosome 7, and several SNPs in the intergenic area of chromosome 2 achieved the highest levels of association ( 
DISCUSSION
We report the first GWAS of sepsis in ELBW infants. In this unique cohort, we identified several SNPs of potential association, although none met genome-wide significance. The results contain potential clues to newborn genetic susceptibility to sepsis, with several SNPs identified related to innate immunity. Over-represented SNPs were found in FOXC2, FOXL1 (all sepsis), ELMO1, VIL1 (Gram-positive sepsis), RALA, IMMP2L (Gram-negative sepsis) and PIEZO2 (fungal sepsis).
Sepsis is a major comorbidity in the ELBW population, with up to 36% of infants experiencing at least one episode during their hospital stay. 1 32 33 Immature innate and adaptive immune defences, and environmental factors, contribute to a complex multifactorial aetiology. 1 8 Recent evidence also suggests genetic susceptibility to infection in preterm neonates. [6] [7] [8] Epidemiological and twin studies indicate a heritable component in certain infections and their complications in adult populations. 34 35 In neonates, a twin study suggested that genetic risk factors were responsible for 49% of variability in sepsis risk; 7 however, this was not confirmed in a subsequent study of multiple births. 8 Several candidate gene studies examined the association of neonatal sepsis with biologically plausible SNPs in cytokines, cytokine receptors, pathogen recognition receptors, cluster differentiation molecules, endothelial and haemostasis markers. 10-13 36-38 These studies demonstrated varying results, described in a recent systematic review. 14 We performed this study to explore genetic associations in neonatal sepsis with an unbiased genome-wide approach. The NRN's anonymised genomic database provides a sizeable cohort of ELBW infants with genotype and phenotype data. In the analysis of all sepsis, we found over-represented SNPs in proximity to genes encoding forkhead box protein family transcription factors FOXC2 and FOXL1. These genes are involved in intestinal mucosal structure and function, including development of Peyer's patches; alterations could plausibly contribute to risk of LOS via microbial translocation and NEC. [39] [40] [41] [42] There are likely differences in diagnosis, and in the interaction between the environment and genome in EOS compared with LOS. 21 To assess LOS as a distinct disease entity, we performed a secondary analysis to identify SNPs associated with LOS alone. As LOS comprised the majority of sepsis cases, the findings of this analysis were very similar to those previously mentioned in all sepsis. We also examined SNPs associated with known specific pathogen categories in LOS. In the analysis of Gram-positive LOS, over-represented SNPs were found in ELMO1 (chromosome 7), which promotes phagocytosis and cell migration (table 2) . [43] [44] [45] Our exploratory analysis of SNPs that have been previously tested in candidate gene association studies yielded trends of interest in gene variants located in tumour necrosis factor, interleukin (IL)-6, IL-10RA, toll like receptor (TLR)-2 and TLR-4 (see online supplementary table S2). While none reached target levels of significance in our study, these trends warrant further exploration in replication cohorts.
Traditional GWAS and candidate gene analyses examine significance at the level of individual SNPs and genes. This approach risks missing modest but more meaningful changes in multiple genes involved in a biological pathway. 46 In contrast, a pathway analysis approach uncovers enrichment of 'significant' SNPs in groups of related genes. 29 30 The strongest pathway associations were noted in Gram-negative sepsis, where pathways involving regulation of gap junctions and connexin function had low FDR estimates (see online supplementary table S3). Connexin proteins provide the framework for gap junction hemichannels, which play an important role in migration and intracellular signalling in immune cells. 47 Downregulation of gap junction channels results from inflammation and infection. [48] [49] [50] [51] Several pathways regulating fibroblast growth factor receptors were also significantly enriched (see online supplementary table S3) and are implicated in attachment and replication of certain pathogens. [52] [53] [54] [55] Pathways related to gap junction channels and fibroblast growth factor receptors may play important roles in mediating respiratory and gut mucosal integrity. 50 51 55 On analysing expression quantitative trait loci (eQTL), ELMO1 levels were noted to be regulated mostly in the gastrointestinal tract, in addition to vasculature. This finding preliminarily suggests a role for alteration in gastrointestinal ELMO1 expression in sepsis. Lastly, IRAK-2, a known component of the classical pro-inflammatory signalling pathway activated by infection, was also identified as enriched in patients that developed Gram-positive sepsis. 57 Our moderately powered study did not identify SNPs that achieved significance at the genome-wide level, indicating that genetic susceptibility to sepsis may be mediated by more than just one or a few SNPs. We did find several overexpressed SNPs at our targeted 'discovery' association levels (10 −6 to 10 −7 ) in genes related to cell migration, phagocytosis and cytokine function. We also identified pathways related to innate immune receptors, maintenance of mucosal homeostasis and barrier defence mechanisms, and cellular signalling that were enriched in patients who developed sepsis. Adaptive immunity is poorly developed in extremely premature infants; the immune response to infectious insults is therefore reliant on innate immune pathways. 58 We speculate that the identified variants, and pathways that they are involved in, may regulate key aspects of the premature neonate's innate immune response, leading to alterations in susceptibility to sepsis. Alteration of gut and respiratory epithelial integrity mediated by these pathways may be an important mechanism of increased sepsis and NEC risk.
The relatively modest size of our cohort imposes limitations on the statistical power of this GWAS. While adult GWAS have been larger, this is the largest ELBW neonatal population with complete genotyping and sepsis-specific phenotype data available. Our study provides novel insights into potential heritable factors for sepsis predilection in this extremely vulnerable population. The smaller sample sizes of subgroups limited conclusions that could be drawn from subgroup analyses and also restricted our ability to perform analyses of specific phenotypic subgroups such as meningitis without bacteraemia. We limited our analysis to a stringent definition of sepsis (culture-proven infection that was treated with a prolonged course of antibiotics). Other limitations include the multiethnic population (fairly representative of the US preterm birth population). To address this, we used eigenvalues to represent ancestry in the analysis, which allowed more complete use of the data set but precluded any inferences related to specific racial or ethnic subgroups. This data set contained 70 identical twins, with separate clinical data on each; SNPs were run on the first sample in an identical twin set (with blinding to clinical phenotype), and SNP results were ascribed to both twins. As we used anonymised clinical data collected in a general database, we possessed limited information on the temporality of comorbidities in relation to the sepsis event. As a result, NEC and other comorbidities could not be reliably accounted for as covariates in the analyses.
We provide data on the role of genetic variants in predisposition to sepsis in extremely premature neonates. While no genes achieved genome-wide significance, several SNPs in genes and pathways relevant to innate immunity were identified with our screening approach using 'target' levels of significance. Additional pathway analyses and gene expression profiling studies could help better understand interactions and downstream effects of these genetic variations in neonatal sepsis. It is essential to ascertain whether these SNPs and pathways related to them continue to demonstrate an association with sepsis in additional cohorts of ELBW infants. 
